http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021228222-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_477168f6ef414d265d7cbfae89a6d49b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
filingDate 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fa5be5fbf7e6d7f2bea40b6de73cb9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc2d35c5b99594653e1e0609f9cb1222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a14130e73c52bc30d28b46eb1935e3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d539dc40a5fbea5821d22a24d80a99c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_303472090d7f3477f33de54aa78ee8ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca376dd6540614af8e788c9a23dd9dd2
publicationDate 2021-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021228222-A1
titleOfInvention Combination for treating hepatitis b
abstract The present invention relates to a combination of a compound represented by formula (I) and other drugs for treating hepatitis B that is used for treating hepatitis B, and use of the combination in the preparation of drugs for treating hepatitis B.
priorityDate 2020-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019169539-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018161960-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016128335-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468029007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465544561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146330379
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146330372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407109560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407109562

Total number of triples: 37.